WCM Investment Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-113,860
| Closed | -$6.43M | – | 310 |
|
|
2024
Q3 | $6.43M | Sell |
113,860
-2,684
| -2% | -$152K | 0.01% | 161 |
|
|
2024
Q2 | $5.25M | Sell |
116,544
-486
| -0.4% | -$21.9K | 0.01% | 161 |
|
|
2024
Q1 | $7.75M | Sell |
117,030
-37,634
| -24% | -$2.49M | 0.02% | 149 |
|
|
2023
Q4 | $6.35M | Buy |
154,664
+57,122
| +59% | +$2.34M | 0.02% | 156 |
|
|
2023
Q3 | $3.11M | Buy |
97,542
+2,329
| +2% | +$74.2K | 0.01% | 169 |
|
|
2023
Q2 | $3.8M | Buy |
95,213
+11,187
| +13% | +$447K | 0.01% | 169 |
|
|
2023
Q1 | $3.59M | Buy |
84,026
+885
| +1% | +$37.8K | 0.01% | 168 |
|
|
2022
Q4 | $3.99M | Buy |
+83,141
| New | +$3.99M | 0.01% | 166 |
|